$FTII
Futuretech II Acquisition Corp Stock $ftii

$ftii Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000149315224013334 Filed on April 05, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$171.9K	$1.063M
YoY Change	-7.44%	59.49%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$171.9K	$1.063M
YoY Change	-7.44%	59.49%
Operating Profit
YoY Change
Interest Expense	$819.7K	$4.809M
YoY Change	-18.16%	4709.1%
% of Operating Profit
Other Income/Expense, Net		$4.954M
YoY Change		195.45%
Pretax Income	$792.3K	$3.891M
YoY Change	-2.89%	285.13%
Income Tax	$185.7K	$979.3K
% Of Pretax Income	23.43%	25.17%
Net Earnings	$606.6K	$2.912M
YoY Change	19.97%	315.92%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.06	$0.23
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.58K	$17.58K
YoY Change	-93.31%	-93.31%
Cash & Equivalents	$17.58K
Short-Term Investments
Other Short-Term Assets	$64.04K	$64.04K
YoY Change	-59.37%	-59.37%
Inventory
Prepaid Expenses	$64.04K
Receivables
Other Receivables
Total Short-Term Assets	$938.5K	$938.5K
YoY Change	123.26%	123.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$61.84M	$61.84M
YoY Change	-48.02%	-48.02%
Other Assets
YoY Change
Total Long-Term Assets	$61.84M	$61.84M
YoY Change	-48.06%	-48.06%
TOTAL ASSETS
Total Short-Term Assets	$938.5K	$938.5K
Total Long-Term Assets	$61.84M	$61.84M
Total Assets	$62.78M	$62.78M
YoY Change	-47.46%	-47.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$295.1K	$295.1K
YoY Change	126.63%	126.63%
Accrued Expenses	$739.5K	$739.5K
YoY Change	264.79%	264.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.122M	$2.122M
YoY Change	169.44%	169.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.450M	$3.450M
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$3.450M	$3.450M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.122M	$2.122M
Total Long-Term Liabilities	$3.450M	$3.450M
Total Liabilities	$5.572M	$5.572M
YoY Change	31.49%	31.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.327M
YoY Change	3.01%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$57.21M	$57.21M
YoY Change
Total Liabilities & Shareholders Equity	$62.78M	$62.78M
YoY Change	-47.46%	-47.46%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$606.6K	$2.912M
YoY Change	19.97%	315.92%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$799.8K	-$1.766M
YoY Change	1116.47%	193.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$375.0K	$61.82M
YoY Change		-152.7%
Cash From Investing Activities	-$375.0K	$61.82M
YoY Change		-152.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.187M	-60.30M
YoY Change		-151.03%
NET CHANGE
Cash From Operating Activities	-799.8K	-1.766M
Cash From Investing Activities	-375.0K	61.82M
Cash From Financing Activities	1.187M	-60.30M
Net Change In Cash	12.08K	-245.2K
YoY Change	-118.37%	-195.12%
FREE CASH FLOW
Cash From Operating Activities	-$799.8K	-$1.766M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001889450
CY2022Q4	FTII	Extension Fee Receivable ExtensionFeeReceivable		usd
CY2022Q4	FTII	Due From Sponsor DueFromSponsor		usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2022Q4	FTII	Excise Tax Payable ExciseTaxPayable		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates		usd
CY2022	FTII	Cash In Transit To Trust CashInTransitToTrust		usd
CY2022	FTII	Proceeds From Cash Withdrawn From Trust ProceedsFromCashWithdrawnFromTrust		usd
CY2023	us-gaap	Proceeds From Sale Of Interest In Partnership Unit ProceedsFromSaleOfInterestInPartnershipUnit		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023	us-gaap	Repayments Of Accounts Receivable Securitization RepaymentsOfAccountsReceivableSecuritization		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	FTII	Capital Contribution From Sponsor CapitalContributionFromSponsor		usd
CY2022	FTII	Payments Of Cash Paid For Redemptions PaymentsOfCashPaidForRedemptions		usd
CY2022	FTII	Excise Tax On Class Common Stock Redemptions ExciseTaxOnClassCommonStockRedemptions		usd
CY2023	FTII	Deferred Underwriting Commission Non Cash DeferredUnderwritingCommissionNonCash		usd
CY2023	FTII	Initial Classification Of Class Common Stock Subject To Redemption InitialClassificationOfClassCommonStockSubjectToRedemption		usd
CY2023	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2022Q4	FTII	Due From Sponsor DueFromSponsor		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41289
CY2023	dei	Entity Registrant Name EntityRegistrantName	FUTURETECH II ACQUISITION CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2551539
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	128 Gail Drive
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New Rochelle
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10805
CY2023	dei	City Area Code CityAreaCode	(914)
CY2023	dei	Local Phone Number LocalPhoneNumber	316-4805
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	122935000	usd
CY2023	dei	Auditor Firm AuditorFirmId	3686
CY2023	dei	Auditor Name AuditorName	Adeptus Partners, LLC
CY2023	dei	Auditor Location AuditorLocation	Ocean, New Jersey
CY2023Q4	us-gaap	Cash Cash	17578	usd
CY2022Q4	us-gaap	Cash Cash	262756	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	64043	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	157614	usd
CY2023Q4	FTII	Extension Fee Receivable ExtensionFeeReceivable	125000	usd
CY2023Q4	FTII	Due From Sponsor DueFromSponsor	731912	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	938533	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	420370	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	61839164	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	118976585	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	77654	usd
CY2023Q4	us-gaap	Assets Assets	62777697	usd
CY2022Q4	us-gaap	Assets Assets	119474609	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	295138	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	130225	usd
CY2023Q4	FTII	Excise Tax Payable ExciseTaxPayable	642389	usd
CY2023Q4	FTII	Franchise Tax Payable Current FranchiseTaxPayableCurrent	94364	usd
CY2022Q4	FTII	Franchise Tax Payable Current FranchiseTaxPayableCurrent	200000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1087603	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	310259	usd
CY2023Q4	FTII	Accrued Offering Costs Current AccruedOfferingCostsCurrent	2708	usd
CY2022Q4	FTII	Accrued Offering Costs Current AccruedOfferingCostsCurrent	2708	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	144443	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2122202	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	787635	usd
CY2023Q4	FTII	Deferred Underwriting Commission DeferredUnderwritingCommission	3450000	usd
CY2022Q4	FTII	Deferred Underwriting Commission DeferredUnderwritingCommission	3450000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5572202	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4237635	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3327054	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3229704	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3326702	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3229352	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62777697	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119474609	usd
CY2023	FTII	Franchise Tax FranchiseTax	200000	usd
CY2022	FTII	Franchise Tax FranchiseTax	200000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	742699	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	366311	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	666311	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4809102	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	144443	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3890846	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1010274	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	979344	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	310259	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2911502	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	700015	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	24562	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	115000000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2239502	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5200750	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3450000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-117300000	usd
CY2022	FTII	Adjustment To Additional Paid In Capital Remeasurement Adjustment AdjustmentToAdditionalPaidInCapitalRemeasurementAdjustment	-1166327	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	700015	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3229352	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3229352	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	6304759	usd
CY2023	FTII	Stock Issued During Period Value Excise Tax On Class A Common Stock Redemption StockIssuedDuringPeriodValueExciseTaxOnClassACommonStockRedemption	-642389	usd
CY2023	FTII	Stock Issued During Period Value Capital Contribution StockIssuedDuringPeriodValueCapitalContribution	3938287	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2911502	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2911502	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3326702	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3326702	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2911502	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	700015	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4809102	usd
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1676585	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	144443	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-93571	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	157614	usd
CY2023	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	731912	usd
CY2023	FTII	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-105636	usd
CY2022	FTII	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	200000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	777344	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	310259	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-77654	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	77654	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	164913	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	100225	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1766109	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-601354	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2800000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	117300000	usd
CY2023	FTII	Cash In Transit To Trust CashInTransitToTrust	-125000	usd
CY2023	FTII	Proceeds From Cash Withdrawn From Trust ProceedsFromCashWithdrawnFromTrust	64746521	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	61821521	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117300000	usd
CY2022	us-gaap	Proceeds From Sale Of Interest In Partnership Unit ProceedsFromSaleOfInterestInPartnershipUnit	115000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5200750	usd
CY2022	FTII	Underwriting Fee Paid UnderwritingFeePaid	-1725000	usd
CY2022	us-gaap	Repayments Of Accounts Receivable Securitization RepaymentsOfAccountsReceivableSecuritization	100000	usd
CY2022	FTII	Proceeds From Repayments Of Accounts Receivable ProceedsFromRepaymentsOfAccountsReceivable	100000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	316640	usd
CY2023	FTII	Capital Contribution From Sponsor CapitalContributionFromSponsor	-3938297	usd
CY2023	FTII	Payments Of Cash Paid For Redemptions PaymentsOfCashPaidForRedemptions	64238887	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-60300590	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	118159111	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-245178	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	257756	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	262756	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17578	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	262756	usd
CY2023	FTII	Excise Tax On Class Common Stock Redemptions ExciseTaxOnClassCommonStockRedemptions	642389	usd
CY2022	FTII	Deferred Underwriting Commission Non Cash DeferredUnderwritingCommissionNonCash	3450000	usd
CY2022	FTII	Initial Classification Of Class Common Stock Subject To Redemption InitialClassificationOfClassCommonStockSubjectToRedemption	118553638	usd
CY2023	FTII	Remeasurement Adjustment RemeasurementAdjustment	6304759	usd
CY2022	FTII	Remeasurement Adjustment RemeasurementAdjustment	3929281	usd
CY2022	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	187993	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	117300000	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2023Q4	FTII	Shares Redemptionof Business Combination Not Completed SharesRedemptionofBusinessCombinationNotCompleted	0.50	pure
CY2023	us-gaap	Interest Expense InterestExpense	100000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zwsUcv3LKsig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zWQbRfWi1FQg">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z7V0b0CZSN37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z1OORB4jOjD5">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zmu9A01KYts9" title="Cash FDIC insured amount">250,000</span>. At December 31, 2023 and, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FUTURETECH II ACQUISITION CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 - Summary of Significant Accounting Policies (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Cash	17578	usd
CY2022Q4	us-gaap	Cash Cash	262756	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	117300000	usd
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	61839164	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	118976585	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	115000000	usd
CY2022Q1	FTII	Proceeds Allocated To Public Warrants ProceedsAllocatedToPublicWarrants	-1067463	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5635551	usd
CY2022Q1	FTII	Due To Common Stock Aggregate Amount Of Redemption Requirement DueToCommonStockAggregateAmountOfRedemptionRequirement	9003014	usd
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	117300000	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1166326	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	118466326	usd
CY2023	FTII	Due To Common Stock Aggregate Amount Of Redemption Requirement DueToCommonStockAggregateAmountOfRedemptionRequirement	-64238888	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	6304759	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	61839164	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	118976585	usd
CY2022Q3	FTII	Percentage Of Exercise Tax To Be Imposed PercentageOfExerciseTaxToBeImposed	0.01	pure
CY2022Q3	FTII	Percentage Of Exercise Tax To Be Imposed PercentageOfExerciseTaxToBeImposed	0.01	pure
CY2023Q4	FTII	Due From Sponsor DueFromSponsor	731912	usd
CY2023	us-gaap	Sponsor Fees SponsorFees	10000	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	120000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	100000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	20	pure
CY2023Q4	FTII	Startup Costs StartupCosts	162267	usd
CY2022Q4	FTII	Startup Costs StartupCosts	98101	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	162267	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	98101	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	162267	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	98101	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	979344	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	310259	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	162267	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	98101	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	162267	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	98101	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	979344	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	310259	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	162267	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	98101	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	FTII	Effective Valuation Allowance EffectiveValuationAllowance	0.042	pure
CY2022	FTII	Effective Valuation Allowance EffectiveValuationAllowance	0.098	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.252	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.308	pure

Files In Submission

Name	View Source	Status
0001493152-24-013334-index-headers.html	Edgar Link	pending
0001493152-24-013334-index.html	Edgar Link	pending
0001493152-24-013334.txt	Edgar Link	pending
0001493152-24-013334-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-5.htm	Edgar Link	pending
ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
ftii-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ftii-20231231_cal.xml	Edgar Link	unprocessable
ftii-20231231_lab.xml	Edgar Link	unprocessable
ftii-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ftii-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FTII
Futuretech II Acquisition Corp Stock $ftii

2023 Q4 Form 10-K Financial Statement

#000149315224013334 Filed on April 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTII Futuretech II Acquisition Corp Stock $ftii

2023 Q4 Form 10-K Financial Statement

#000149315224013334 Filed on April 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTII
Futuretech II Acquisition Corp Stock $ftii